| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| SELL | SELL | SELL | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 45.65▼ | 45.69▼ | 45.83▼ | 45.57▲ | 46.61▼ |
| MA10 | 45.61▼ | 45.87▼ | 46.09▼ | 46.14▼ | 50.67▼ |
| MA20 | 45.66▼ | 46.05▼ | 45.47▲ | 45.97▼ | 52.20▼ |
| MA50 | 45.92▼ | 45.33▲ | 45.89▼ | 50.99▼ | 65.35▼ |
| MA100 | 46.12▼ | 45.80▼ | 46.29▼ | 51.66▼ | 104.08▼ |
| MA200 | 45.58▲ | 46.33▼ | 45.88▼ | 56.67▼ | 114.16▼ |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.022▲ | -0.107▼ | 0.024▲ | 0.273▲ | 0.469▲ |
| RSI | 42.266▼ | 46.065▼ | 48.598▼ | 45.624▼ | 38.525▼ |
| STOCH | 50.332 | 14.996▼ | 38.076 | 42.579 | 32.190 |
| WILL %R | -64.000 | -88.312▼ | -45.946 | -66.666 | -67.633 |
| CCI | 33.292 | -118.372▼ | -45.522 | -34.006 | -82.705 |
|
Friday, September 12, 2025 11:44 AM
Expanded indication provides patients with knee osteoarthritis the benefits of Embosphere’s consistent, predictable, and effective clinical results.SOUTH JORDAN, Utah, Sept. 12, 2025 (GLOBE NEWSWIRE) ...
|
|
Monday, September 08, 2025 06:26 AM
Lifeward (Nasdaq:LFWD) announced today that it received CE mark approval for its ReWalk 7 personal exoskeleton.
|
|
Monday, September 08, 2025 05:42 AM
Seventh generation of industry-leading ReWalk Exoskeleton is now cleared for commercial launch in the European UnionMARLBOROUGH, Mass. and YOKNEAM ILLIT, Sept. 08, 2025 (GLOBE NEWSWIRE) -- Lifeward ...
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 12/09/25 | 46.74 | 46.74 | 45.40 | 45.58 | 716,939 |
| 11/09/25 | 43.99 | 46.97 | 43.84 | 46.87 | 1,728,760 |
| 10/09/25 | 44.50 | 45.63 | 44.05 | 44.22 | 1,934,104 |
| 09/09/25 | 46.285 | 46.37 | 44.51 | 44.68 | 2,473,766 |
| 08/09/25 | 47.84 | 48.16 | 45.65 | 46.52 | 2,091,106 |
| 05/09/25 | 46.51 | 49.3299 | 46.341 | 48.73 | 2,223,201 |
| 04/09/25 | 44.42 | 46.53 | 43.705 | 46.43 | 2,374,062 |
| 03/09/25 | 45.56 | 46.10 | 44.3154 | 44.64 | 1,757,591 |
| 02/09/25 | 46.65 | 46.65 | 44.92 | 46.07 | 1,860,364 |
| 29/08/25 | 46.89 | 47.90 | 46.85 | 47.63 | 1,801,423 |
|
|
||||
|
|
||||
|
|